Type 2 Diabetes Mellitus Remission Models Following Laparoscopic Gastric Bypass: a 4-Model Analysis in a Latino Population.
ABCD score
Ad-DiaRem
Bariatric surgery
DiaBetter
DiaRem
Diabetes remission score
Laparoscopic gastric bypass
Metabolic surgery
Mexican
Obesity
Type 2 diabetes mellitus
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
03
05
2020
accepted:
11
08
2020
revised:
11
08
2020
pubmed:
19
8
2020
medline:
20
4
2021
entrez:
19
8
2020
Statut:
ppublish
Résumé
Bariatric surgery is indicated for major weight loss and for the control of associated comorbidities, particularly type 2 diabetes. Remission prediction scores have been proposed for this end, such as: DiaRem, Ad-DiaRem, ABCD, and DiaBetter. Nevertheless, they have not been evaluated all together in a specific population. Retrospective study with Mexican patients submitted to gastric bypass with at least 12 months follow-up. All patients had BMI > 30 kg/m A total of 95 patients were included. Mean age 44 years, 85.6% female with mean BMI of 44.1 kg/m In Mexican patients with obesity and type 2 Diabetes, submitted to gastric bypass, remission prediction could be assessed with any current model showing satisfactory sensibility and specificity. Among such models, DiaBetter obtained the best statistical performance in our population. Type 2 diabetes remission rate at 1 year is similar to any other race or ethnicity.
Sections du résumé
BACKGROUND
Bariatric surgery is indicated for major weight loss and for the control of associated comorbidities, particularly type 2 diabetes. Remission prediction scores have been proposed for this end, such as: DiaRem, Ad-DiaRem, ABCD, and DiaBetter. Nevertheless, they have not been evaluated all together in a specific population.
METHODS
Retrospective study with Mexican patients submitted to gastric bypass with at least 12 months follow-up. All patients had BMI > 30 kg/m
RESULTS
A total of 95 patients were included. Mean age 44 years, 85.6% female with mean BMI of 44.1 kg/m
CONCLUSION
In Mexican patients with obesity and type 2 Diabetes, submitted to gastric bypass, remission prediction could be assessed with any current model showing satisfactory sensibility and specificity. Among such models, DiaBetter obtained the best statistical performance in our population. Type 2 diabetes remission rate at 1 year is similar to any other race or ethnicity.
Identifiants
pubmed: 32808169
doi: 10.1007/s11695-020-04920-7
pii: 10.1007/s11695-020-04920-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
544-553Références
Leitner DR, Frühbeck G, Yumuk V, et al. Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies - EASO can lead the way. Obes Facts. 2017;10:483–92. https://doi.org/10.1159/000480525 .
doi: 10.1159/000480525
pubmed: 29020674
pmcid: 5741209
Mandviwala T, Khalid U, Deswal A. Obesity and cardiovascular disease: a risk factor or a risk marker? Curr Atheroscler Rep. 2016;18 https://doi.org/10.1007/s11883-016-0575-4 .
Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2004;110:2952–67. https://doi.org/10.1161/01.CIR.0000145546.97738.1E .
doi: 10.1161/01.CIR.0000145546.97738.1E
pubmed: 15509809
Verma S, Hussain ME. Obesity and diabetes: an update. Diabetes Metab Syndr Clin Res Rev. 2017;11:73–9. https://doi.org/10.1016/j.dsx.2016.06.017 .
doi: 10.1016/j.dsx.2016.06.017
Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14:160–9. https://doi.org/10.1038/nrgastro.2016.170 .
doi: 10.1038/nrgastro.2016.170
pubmed: 27899816
Bray GA, Frühbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016;387:1947–56. https://doi.org/10.1016/S0140-6736(16)00271-3 .
doi: 10.1016/S0140-6736(16)00271-3
pubmed: 26868660
Shah A, Laferrère B. Diabetes after bariatric surgery. Can J Diabetes. 2017;41:401–6. https://doi.org/10.1016/j.jcjd.2016.12.009 .
doi: 10.1016/j.jcjd.2016.12.009
pubmed: 28457649
pmcid: 5875725
Still CD, Wood GC, Benotti P, et al. A probability score for preoperative prediction of type 2 diabetes remission following RYGB surgery. Lancet Diabetes Endocrinol. 2014;2:38–45. https://doi.org/10.1016/S2213-8587(13)70070-6.A .
doi: 10.1016/S2213-8587(13)70070-6.A
pubmed: 24579062
pmcid: 3932625
Aron-Wisnewsky J, Sokolovska N, Liu Y, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. Diabetologia. 2017;60:1892–902. https://doi.org/10.1007/s00125-017-4371-7 .
doi: 10.1007/s00125-017-4371-7
pubmed: 28733906
Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9:379–84. https://doi.org/10.1016/j.soard.2012.07.015 .
doi: 10.1016/j.soard.2012.07.015
pubmed: 22963817
Pucci A, Tymoszuk U, Cheung WH, et al. Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med. 2018;35:360–7. https://doi.org/10.1111/dme.13532 .
doi: 10.1111/dme.13532
pubmed: 29055156
Zhang R, Borisenko O, Telegina I, et al. Systematic review of risk prediction models for diabetes after bariatric surgery. Br J Surg. 2016;103:1420–7. https://doi.org/10.1002/bjs.10255 .
doi: 10.1002/bjs.10255
pubmed: 27557164
Alegre-Díaz J, Herrington W, López-Cervantes M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375:1961–71. https://doi.org/10.1056/NEJMoa1605368 .
doi: 10.1056/NEJMoa1605368
pubmed: 27959614
pmcid: 5215048
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5. https://doi.org/10.2337/dc09-9036 .
doi: 10.2337/dc09-9036
pubmed: 19875608
pmcid: 2768219
Zerrweck-Lopez C. Origen del “bypass gastrico simplificado.” Cir y Cir (English Ed 2015;83:87–8. https://doi.org/10.1016/j.circir.2015.04.030 .
Espinosa O, Pineda O, Maydón HG, et al. Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m 2 using strict remission criteria: early outcomes of a prospective study among Mexicans. Surg Endosc. 2018;32:1353–9. https://doi.org/10.1007/s00464-017-5815-3 .
doi: 10.1007/s00464-017-5815-3
pubmed: 28812155
Aminian A, Brethauer SA, Andalib A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity. Ann Surg. 2017;266:650–7. https://doi.org/10.1097/SLA.0000000000002407 .
doi: 10.1097/SLA.0000000000002407
pubmed: 28742680
Cohen RV, Shikora S, Petry T, et al. The diabetes surgery summit II guidelines: a disease-based clinical recommendation. Obes Surg. 2016;26:1989–91. https://doi.org/10.1007/s11695-016-2237-6 .
doi: 10.1007/s11695-016-2237-6
pubmed: 27189354
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–256.e5. https://doi.org/10.1016/j.amjmed.2008.09.041 .
doi: 10.1016/j.amjmed.2008.09.041
pubmed: 19272486
Ng J, Seip R, Stone A, et al. Ethnic variation in weight loss, but not co-morbidity remission, after laparoscopic gastric banding and Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015;11:94–100. https://doi.org/10.1016/j.soard.2014.07.013 .
doi: 10.1016/j.soard.2014.07.013
pubmed: 25547051
Kodama S, Fujihara K, Horikawa C, et al. Network meta-analysis of the relative efficacy of bariatric surgeries for diabetes remission. Obes Rev. 2018;19:1621–9. https://doi.org/10.1111/obr.12751 .
doi: 10.1111/obr.12751
pubmed: 30270528
Zorrilla-Nunez LF, Campbell A, Giambartolomei G, et al. The importance of the biliopancreatic limb length in gastric bypass: a systematic review. Surg Obes Relat Dis. 2019;15:43–9. https://doi.org/10.1016/j.soard.2018.10.013 .
doi: 10.1016/j.soard.2018.10.013
pubmed: 30501957
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Obes Surg. 2017;27:2–21. https://doi.org/10.1007/s11695-016-2457-9 .
doi: 10.1007/s11695-016-2457-9
pubmed: 27957699
Madadi F, Jawad R, Mousati I, et al. Remission of type 2 diabetes and sleeve gastrectomy in morbid obesity: a comparative systematic review and meta-analysis. Obes Surg. 2019;29:4066–76. https://doi.org/10.1007/s11695-019-04199-3 .
doi: 10.1007/s11695-019-04199-3
pubmed: 31655953
Borgeraas H, Hofsø D, Hertel JK, et al. Comparison of the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2020;21:1–11. https://doi.org/10.1111/obr.13011 .
doi: 10.1111/obr.13011
Dicker D, Golan R, Aron-Wisnewsky J, et al. Prediction of long-term diabetes remission after RYGB, sleeve gastrectomy, and adjustable gastric banding using DiaRem and advanced-DiaRem scores. Obes Surg. 2019;29:796–804. https://doi.org/10.1007/s11695-018-3583-3 .
doi: 10.1007/s11695-018-3583-3
pubmed: 30467708
Wong RJ, Chou C, Sinha SR, et al. Ethnic disparities in the association of body mass index with the risk of hypertension and diabetes. J Community Health. 2014;39:437–45. https://doi.org/10.1007/s10900-013-9792-8 .
doi: 10.1007/s10900-013-9792-8
pubmed: 24276618
Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology. Surg Obes Relat Dis. 2019;16:175–247. https://doi.org/10.1016/j.soard.2019.10.025 .
doi: 10.1016/j.soard.2019.10.025
pubmed: 31917200
Ramírez EM, Espinosa O, Berrones R, et al. The impact of preoperative BMI (obesity class I, II, and III) on the 12-month evolution of patients undergoing laparoscopic gastric bypass. Obes Surg. 2018;28:3095–101. https://doi.org/10.1007/s11695-018-3281-1 .
doi: 10.1007/s11695-018-3281-1
pubmed: 29725974